Abstract
It has been revealed that various therapeutic agents for lifestyle-related diseases could affect bone metabolism. For example, thiazolidines, loop diuretics and warfarin would be possibly disadvantageous to bone metabolism. In many cases with lifestyle-related disease, it is necessary to take the medicine over a long term. Therefore, we should pay enough attention to bone metabolism during the selection of medicine, especially in the treatment of a high risk group for bone fracture. However, a majority of these drugs lack the evidence with randomized controlled trials for osteoporotic fracture. Further clinical research should be required to clarify the impact of each drug on osteoporosis with lifestyle-related diseases.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
